Explore more publications!

Press Releases

Pakistan Leads 2025 Global Pollution Rankings

Pakistan Leads 2025 Global Pollution Rankings

Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities
Availability of the 2025 Universal Registration Document, terms for holding the Combined General Meeting of Unibail-Rodamco-Westfield SE on May 6, 2026, and availability of the explanatory documentation
Valneva Reports Full Year 2025 Audited Consolidated Financial Results
Valneva Provides Update on Recommendations for Use of IXCHIQ® in the United Kingdom
TGR Foundation Celebrates 20 Years of Impact Through Education at TGR Learning Lab in Anaheim
Hypersante Introduces the 2026 Longevity and Biohacking Summit in Paris
Chef Andreas Debuts Andreas Prime Steaks & Seafood in Uptown Dallas, Reuniting His Culinary Team from The Palm
Deputy President Shipokosa Paulus Mashatile: Heritage Day 2025

Deputy President Shipokosa Paulus Mashatile: Heritage Day 2025

Statement on the Cabinet meeting of Wednesday, 17 September 2025

Statement on the Cabinet meeting of Wednesday, 17 September 2025

EU Balance of Payments and International Investment Position statistical sources and methods - B.o.p. and i.i.p. e-book

EU Balance of Payments and International Investment Position statistical sources and methods - B.o.p. and i.i.p. e-book

Public Health Action Network Is A Partnering Organization for the  'Healthy Indoor Air' Event at the UN General Assembly
OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance -  Publication of Circular for Combined Annual General Meeting of  September 30, 2025
Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.
Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information
Combined General Meeting of June 13, 2025
Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ®
Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States
Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions